Follow
Mikael Hoffmann
Mikael Hoffmann
NEPI, Linköping university
Verified email at nepi.net
Title
Cited by
Cited by
Year
The first decade with the Swedish prescribed drug register–a systematic review of the output in the scientific literature
SM Wallerstedt, B Wettermark, M Hoffmann
Basic & clinical pharmacology & toxicology 119 (5), 464-469, 2016
2202016
The Nordic prescription databases as a resource for pharmacoepidemiological research—a literature review
B Wettermark, H Zoëga, K Furu, M Korhonen, J Hallas, M Nørgaard, ...
Pharmacoepidemiology and drug safety 22 (7), 691-699, 2013
2032013
Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance
B Godman, B Wettermark, M Hoffmann, K Andersson, A Haycox, ...
Expert review of pharmacoeconomics & outcomes research 9 (1), 65-83, 2009
1842009
Dabigatran–a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs
RE Malmström, BB Godman, E Diogene, C Baumgärtel, M Bennie, ...
Frontiers in pharmacology 4, 39, 2013
1192013
Changes in women's attitudes towards and use of hormone therapy after HERS and WHI
M Hoffmann, M Hammar, KI Kjellgren, L Lindh-Åstrand, J Brynhildsen
Maturitas 52 (1), 11-17, 2005
1042005
Women's conception of the menopausal transition–a qualitative study
L Lindh‐Åstrand, M Hoffmann, M Hammar, KI Kjellgren
Journal of Clinical Nursing 16 (3), 509-517, 2007
1032007
Pharmacokinetics of nicotine in kidney failure
L Molander, A Hansson, E Lunell, L Alainentalo, M Hoffmann, R Larsson
Clinical Pharmacology & Therapeutics 68 (3), 250-260, 2000
662000
High incidence of antibiotic resistance among bacteria in 4 intensive care units at a university hospital in Sweden
HÅK Hanberger, M Hoffmann, S Lindgren, LE Nilsson
Scandinavian journal of infectious diseases 29 (6), 607-614, 1997
581997
14-year survey in a Swedish county reveals a pronounced increase in bloodstream infections (BSI). Comorbidity-an independent risk factor for both BSI and mortality
M Holmbom, CG Giske, M Fredrikson, Å Östholm Balkhed, C Claesson, ...
PLoS one 11 (11), e0166527, 2016
532016
Utilization and costs of lipid modifying therapies following health technology assessment for the new reimbursement scheme in Sweden
B Pettersson, M Hoffmann, P Wändell, LÅ Levin
Health policy 104 (1), 84-91, 2012
462012
The prevalence of symptoms possibly related to the climacteric in pre-and postmenopausal women in Linköping, Sweden
C Jansson, S Johansson, L Lindh-Åstrand, M Hoffmann, M Hammar
Maturitas 45 (2), 129-135, 2003
412003
Attitudes towards the menopause and hormone therapy over the turn of the century
L Lindh-Åstrand, J Brynhildsen, M Hoffmann, S Liffner, M Hammar
Maturitas 56 (1), 12-20, 2007
372007
The right drug, but from whose perspective? A framework for analysing the structure and activities of drug and therapeutics committees
M Hoffmann
European journal of clinical pharmacology 69, 79-87, 2013
332013
Hot flushes, hormone therapy and alternative treatments: 30 years of experience from Sweden
L Lindh-Åstrand, M Hoffmann, M Hammar, AC Spetz Holm
Climacteric 18 (1), 53-62, 2015
322015
Hormone therapy might be underutilized in women with early menopause
L Lindh-Åstrand, M Hoffmann, L Järvstråt, M Fredriksson, M Hammar, ...
Human Reproduction 30 (4), 848-852, 2015
292015
Phases in development of an interactive mobile phone-based system to support self-management of hypertension
I Hallberg, C Taft, A Ranerup, U Bengtsson, M Hoffmann, S Höfer, ...
Integrated blood pressure control, 19-28, 2014
282014
Hormone replacement therapy in the menopause: Structure and content of risk talk
M Hoffmann, L Lindh-Åstrand, J Ahlner, M Hammar, KI Kjellgren
Maturitas 50 (1), 8-18, 2005
252005
Generic pregabalin: current situation and implications for health authorities, generics and biosimilars manufacturers in the future
B Godman, M Wilcock, A Martin, S Bryson, C Baumgärtel, T Bochenek, ...
Generics and Biosimilars Initiative Journal 4 (3), 125-135, 2015
242015
Risk talk: rhetorical strategies in consultations on hormone replacement therapy
M Hoffmann, P Linell, L Lindh-Åstrand, K Kjellgren
Health, Risk & Society 5 (2), 139-154, 2003
232003
Surveillance of antibiotic resistance in ICUs in southeastern Sweden
CM Erlandsson, H Hanberger, I Eliasson, M Hoffmann, B Isaksson, ...
Acta anaesthesiologica scandinavica 43 (8), 815-820, 1999
221999
The system can't perform the operation now. Try again later.
Articles 1–20